Trastuzumab Side Effects

Herceptin HYLECTA™ (trastuzumab and hyaluronidase-oysk trastuzumab Trastuzumab emtansine binds to the HER2 receptor's sub-domain IV and goes into the cell by receptor-mediated endocytosis Lysosomes degrade trastuzumab trastuzumab Trastuzumab prolongs survival in metastatic breast cancer patients whose tumors over express HER2 It is effective when given as a single agent or in

trastuzumab trastuzumab beyond progression Trastuzumab is generally well tolerated and does not cause many of the toxicities or side effects seen with conventional